Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective.

Scemblix (asciminib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42807211

Christopher Hillis; Dennis Dong Hwan Kim; Lambert Busque; Mary Lynn Savoie; Pierre Laneuville

Sep 30, 2026